STYLE 115 SILICONE GEL FILLED BREAST IMPLANT
Report
- Report Number
- 2024601-2011-00780
- Event Type
- Injury
- Date Received
- September 13, 2011
- Date of Event
- August 11, 2011
- Report Date
- August 22, 2011
- Manufacturer
- ALLERGAN
- Product Code
- FTR
- PMA / PMN Number
- P020056
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER
Narratives
MEDWATCH SUBMITTED ON (B)(4) 2011. DEVICE LABELING ADDRESSES THE REPORTED EVENT OF SEROMA AND CAPSULAR CONTRACTURE AS FOLLOWS: THE CORE STUDY: 7 YEAR ADVERSE EVENT RATES: FOR PRIMARY AUGMENTATION PATIENTS, SEROMA RATE = 1.6 PERCENT. CAPSULAR CONTRACTURE 15.5 PERCENT. SWELLING = 7.1 PERCENT. "AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR AND/OR PERSIST, WITH VARYING INTENSITY AND/OR FOR A VARYING LENGTH OF TIME: HEMATOMA/SEROMA..." (ALLERGAN SILICONE LABELING). DEVICE LABELING REVIEWED: THERE WERE NO REPORTED EVENTS OF LYMPHOMA/ALCL, FOR PATIENTS IN THE CORE STUDY, IN THE LABELING FOR SILICONE IMPLANTS.
PATIENT REPORTS VIA EMAIL A CASE OF LYMPHOMA. SHE REPORTS THAT SHE IS AN AUGMENTATION PATIENT AND WAS IMPLANTED IN 2007. SHE STATES THAT SHE NOTICED HER IMPLANT GETTING HARD AND WENT TO SEE THE DOCTOR. ON (B)(6) 2011 THE SURGEON CALLS IN TO PROVIDE ADDITIONAL INFORMATION ON THIS PATIENT. HE PRESENTS HER HISTORY AS A RECONSTRUCTION PATIENT. SHE WAS DIAGNOSED WITH RIGHT BREAST CANCER PRIOR TO IMPLANTATION. RECONSTRUCTION SURGERY TOOK PLACE ON (B)(6) 2007, WITH THE LEFT SIDE BEING DONE FOR PROPHYLACTIC PURPOSES. ON (B)(6) 2011 THE PRESENTED WITH CAPSULAR CONTRACTURE BAKER GRADE IV OF THE RIGHT BREAST AND WAS EXPLANTED. THE DIAGNOSIS OF ALCL WAS MADE FROM THE RIGHT BREAST CAPSULE SAMPLE FROM THE (B)(6) 2011 SURGERY. THE PATIENT IS SCHEDULED TO HAVE THE DEVICES REMOVED BILATERALLY (B)(6) 2011.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | STYLE 115 SILICONE GEL FILLED BREAST IMPLANT | FTR | ALLERGAN | NA | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | Required Intervention |